WHO to share vaccines to stop monkeypox amid inequity fears

London: The World Health Organisation said it's creating a new vaccine-sharing mechanism to stop the outbreak of monkeypox in more than 30 countries beyond Africa. The move could result in the U.N. health agency distributing scarce vaccine doses to rich countries that can otherwise afford them.

To some health experts, the initiative potentially misses the opportunity to control monkeypox virus in the African countries where it's infected people for decades, serving as another example of the inequity in vaccine distribution that was seen during the Coronavirus pandemic.

WHO Director-General Tedros Adhanom Ghebreyesus said the agency is developing an initiative for fair access to vaccines and treatments that it hopes will be ready within weeks. The mechanism was proposed shortly after Britain, Canada, France, Germany, the U.S. and other countries reported hundreds of monkeypox cases last month.

Vaccines for smallpox, a related disease, are thought to be about 85% effective against monkeypox. WHO's Europe director, Hans Kluge, said Wednesday he was concerned by the scramble by some rich countries to buy more vaccines without talk of buying supplies for Africa.

Kluge urged governments "to approach monkeypox without repeating the mistakes of the pandemic. Still, he did not discount the possibility that countries like Britain, which currently has the biggest outbreak beyond Africa, might receive vaccines through WHO's mechanism.

He said the program was being created for all countries and that vaccines would largely be dispensed based on their epidemiological needs.

Europe remains the epicenter of this escalating outbreak, with 25 countries reporting more than 1,500 cases, or 85% of the global total, Kluge noted.

Some African experts questioned why the U.N. health agency has never proposed using vaccines in central and West Africa, where the disease is endemic.